Study of NNZ-2566 in Patients With Traumatic Brain Injury Under EFIC

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2013
The purpose of this study is to determine whether NNZ-2566 is safe and effective in the treatment of Traumatic Brain Injury (TBI).
Epistemonikos ID: 929e3cc045a10ab148b0fc9f3f264550bccc9c7a
First added on: May 06, 2024